Stabilization of human pancreatic ribonuclease through mutation at its N-terminal edge

A. Benito, M. Bosch, G. Torrent, M. Ribó and M. Vilanova1

Laboratori d’Enginyeria de Proteïnes, Departament de Biologia, Facultat de Ciències, Universitat de Girona, Campus Montilivi, 17071 Girona, Spain


    Abstract
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Enzyme stability can be an important parameter in the design of recombinant toxins because unstable proteins are often degraded before they can reach their cellular target. There is great interest in the design of human pancreatic ribonuclease variants that could be cytotoxic against tumoral cells. To this end, some residues in the protein need to be substituted, but this may result in a loss of stability. Previous papers have reported the production of N- and C-terminal human pancreatic ribonuclease variants with increased thermal stability. Here, we investigated the contribution of the different amino acid changes at the N-terminus of the protein to its thermostability increase. We show that this increase correlates with the helical propensity of the first {alpha}-helix of the protein. On the other hand, deletion of the four last residues of the protein does not affect its thermal stability. These results set the basis for the design of a human pancreatic ribonuclease template on which amino acid substitutions can be made that could render the enzyme cytotoxic, without an important loss in its stability.

Keywords: helicity/human pancreatic ribonuclease/site-directed mutagenesis/thermal stability


    Introduction
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
The thermodynamic stability of a protein is related to its primary structure (Anfinsen, 1973Go), which is believed to encode a global energy minimum that corresponds to its native structure. Consequently, changes in the amino acid sequence of a protein can lead to changes in its stability. Stabilization of the native state has been achieved by redesigning the primary structure by site-directed mutagenesis. Repacking of the hydrophobic core (Akasako et al., 1997Go), engineering extra disulfide bonds (Perry and Wetzel, 1984Go), hydrogen bonds or salt bridges (Serrano et al., 1992Go), improvement of the secondary structure propensities (Villegas et al., 1996Go; López-Hernández et al., 1997Go) or long range charge–charge interactions (Loladzde et al., 1999) by residue replacements are strategies that have been used to change or characterize protein stability.

Some members of the ribonuclease superfamily are cytotoxic against tumoral cells. Cytotoxicity is exerted because these molecules can reach the cellular cytosol where they degrade RNA by evading the action of the ribonuclease inhibitor (RI). Paradigmatic examples are bovine seminal ribonuclease (BS-RNase) and onconase [for a review, see Youle and D’Alessio (Youle and D’Alessio, 1997Go)]. Although human pancreatic ribonuclease (HP-RNase, EC 3.1.27.5) is inhibited by RI, engineered forms of HP-RNase which could be able either to evade RI or to reach the cytosol, have been proposed as promising candidates for antitumoral drugs, because these variants would probably be more tolerated by the human immune system. In order to ensure cytotoxicity, HP-RNase mutants should maintain their enzymatic activity and stability at physiological temperature (Leland et al., 2001Go). However, since amino acid replacements may alter protein stability, a ribonuclease template with increased stability would increase the chances of producing cytotoxic variants. Correlation between the conformational stability of a protein and its catabolism and consequently its biological actions has been suggested. In recent work (Klink and Raines, 2000Go), the cytotoxicity of bovine pancreatic ribonuclease (RNaseA) variants was linked to its conformational stability.

In this work, we investigated two sets of mutations in highly exposed residues of HP-RNase that have previously been described as increasing enzyme stability. Characterizing this higher degree of stability at the molecular level would be a valuable tool for engineering cytotoxic ribonucleases that maintain or even increase their stability.

On the one hand, we investigated a variant, named PM5, which has been described as increasing the midpoint transition temperature (T1/2) by 5°C with respect to the parental enzyme (Canals et al., 1999Go). PM5 is an HP-RNase variant whose N-terminal sequence (residues 1–21) was replaced by that of BS-RNase. Because of the high degree of sequence homology between both ribonucleases (Beintema et al., 1984Go), only five residues are different between PM5 and the wild-type enzyme. These differences are shown in Figure 1AGo. We produced and characterized five different N-terminal HP-RNase variants with the aim of dissecting the individual contribution of each of the amino acid changes to the increase in protein stability. It is well known, from the three-dimensional structures of RNase A (Wlodawer et al., 1988Go), BS-RNase (Mazarella et al., 1993Go) and two HP-RNase variants very similar to PM5 (Canals et al., 2001Go; Pous et al., 2000Go), that this peptide contains an {alpha}-helix that spans residues 3–4 to residue 12. Our results suggest that the increase in conformational stability correlates with the helical propensity of the N-terminal edge and that global stabilization of HP-RNase may be achieved by local stabilization of secondary structure segments.



View larger version (45K):
[in this window]
[in a new window]
 
Fig. 1. (a) Schematic representation of the sequence differences between HP-RNase variants that appear in the text. Dashed residues at the N-terminus correspond to those that are different between PM9 and PM5. (b) Ribbon diagram of the molecule A of PM7 human pancreatic ribonuclease variant (pdb accession code 1dza). The residues –1, 1, 18–22 and 126–128 were not solved in the crystal structure and have been modelled (Pous et al., 2000Go). Side chains of the residues modified in this work are numbered and shown in black. The figure was drawn with MOL-MOL (Koradi et al., 1996Go).

 
We also investigated another HP-RNase variant with a four-residue deletion at the C-terminal part of the molecule (residues 125–128, see Figure 1Go). It has been stated elsewhere that this truncated protein shows a higher ribonuclease activity and enhanced thermal stability (Bal and Batra, 1997Go). We demonstrate that this C-terminal deletion has no influence on the protein stability.


    Materials and methods
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
HP-RNase variants

Construction of PM5 and PM9 has been described elsewhere (Canals et al., 1999Go). PM9 corresponds to the wild-type HP-RNase carrying an additional methionine at the N-terminus of the protein. PM5 corresponds to a PM9 variant with five additional mutations located in the N-terminus: Arg4 to Ala, Lys6 to Ala, Gln9 to Glu, Asp16 to Gly and Ser17 to Asn. PM7 is a PM5 variant in which Pro50 has been substituted by Ser. For clarity, a capital letter P is used to refer to the protein variant and a lower case letter p to refer to the plasmid carrying the mutated gene.

Construction of N-terminal mutants.

HP-RNase variants carrying the substitutions Arg4 to Ala (R4A), Lys6 to Ala (K6A), Gln9 to Glu (Q9E), Asp16 to Gly (D16G) and Ser17 to Asn (S17N) were constructed using a PCR site-directed mutagenesis methodology described elsewhere (Juncosa-Ginestà et al., 1994Go). Oligonucleotides T7PROM and T7TERM (Canals et al., 1999Go) were used to amplify the HP-RNase gene together with a specific oligonucleotide for each variant: M9R4A (5'-CTT TTT AGC TGC AGA TTC TTT C-3'), M9K6A (5'-GGA ACT TTG CAG CTC TAG ATT C-3'), M9Q9E (5'-GTG TTG TCT TTC GAA CTT TTT AG-3'), M9D16G (5'-GAT GGG GAG CTA CCA GAG TCC ATG TG-3') and M9S17N (5'-GCT CGA TGG GGA GTT ATC AGA GTC-3'). The PCR products were digested with NdeI and SalI restriction enzymes and ligated to pM9, previously digested with the same restriction enzymes. The resulting clones were confirmed by sequence analysis.

Construction of variant pM5-124.

The gene fragment of PM5 coding for amino acids 1–124 was amplified by PCR using oligonucleotides T7PROM and HPR-124 (5'-CCC TCG AGT TAA ACG CTA GCA TCA AAA TG-3'). Oligonucleotide HPR-124 codes for the complementary sequence of the HP-RNase gene from residues 119 to 124 followed by a STOP codon and the recognition sequence of the XhoI restriction enzyme. The amplified fragment was digested with NdeI and XhoI and ligated to pET17b(+) vector, previously digested with the same restriction enzymes. The resulting clone was confirmed by sequence analysis.

Expression and purification

HP-RNase expression and purification have been described elsewhere in detail (Canals et al., 1999Go; Ribó et al., 2001Go). Briefly, overnight cultures of BL21(DE3) cells carrying the desired vector were reinoculated 1:100 and allowed to grow at 37°C with vigorous agitation until protein expression was induced at late log phase by the addition of IPTG to a final concentration of 1 mM. After a further 3–4 h of growth, the cells were harvested by centrifugation and the resulting pellets were stored at –20°C until protein processing. Frozen pellets were thawed and resuspended in 50 mM Tris–HCl, pH 8.0, 10 mM EDTA, disrupted by French press and centrifuged to isolate inclusion bodies. The aggregated protein was dissolved in 6 M guanidinium chloride, 100 mM Tris–acetate, 2 mM EDTA, pH 8.5 and reduced by the addition of reduced glutathione to a final concentration of 0.1 M. The pH was adjusted to 8.5 and the sample was incubated at room temperature under a nitrogen atmosphere for 2 h. After removal of insoluble material by centrifugation, the solubilized protein was diluted 100-fold into 0.1 M Tris–acetate, 0.5 M L-arginine, 1 mM oxidized glutathione, 2 mM EDTA, pH 8.5 and incubated at 10°C for at least 24 h. The sample was then adjusted to pH 5.0, concentrated by tangential ultrafiltration and dialysed exhaustively against 50 mM sodium acetate, pH 5.0. Precipitated or insoluble material was discarded by centrifugation. Refolded ribonucleases were then purified by cation-exchange chromatography on a Mono-S HR 5/5 fast protein liquid chromatography (FPLC) column equilibrated with 50 mM sodium acetate, pH 5.0 and eluted with a linear gradient from 0 to 600 mM NaCl. Fractions containing the pure and homogeneous ribonucleases were dialyzed against ultra-pure water, lyophilized and stored at –20°C until further analysis.

Determination of steady-state kinetic parameters

Spectrophotometric assays (Boix et al., 1994Go) were used to determine the kinetic parameters for the cleavage of poly(cytidylic acid) [poly(C)] and the hydrolysis of cytidine 2',3'-cyclic monophosphate (C>p) by the HP-RNase variants. In the C>p assays, the concentration of enzyme was 0.1 mM, the initial concentration of C>p ranged from 0.1 to 5.5 mM and the activity was measured by recording the increase in absorbance at 296 nm. For assays with poly(C), the concentration of enzyme was 5 nM, the initial concentration of poly(C) ranged from 0.1 to 2.5 mg/ml and the decrease in absorbance at 294 nm was used to monitor the cleavage. All assays were carried out at 25°C in 0.2 M sodium acetate buffer, pH 5.5, using 1 cm pathlength quartz cells for C>p and 0.2 cm pathlength quartz cells for poly(C). Steady-state kinetic parameters were obtained by non-linear regression analysis using the program ENZFITTER (Leatherbarrow, 1987Go). The values in Table IGo are the averages of three determinations, with a standard error of <10%.


View this table:
[in this window]
[in a new window]
 
Table I. T1/2 values and steady-state kinetic parameters for the hydrolysis of C>p and the cleavage of poly(C) of the different constructions described
 
Circular dichroism

Circular dichroism (CD) spectra were recorded at 10°C using a Jasco-J715 spectropolarimeter equipped with a thermostated cell holder from Jasco (Tokyo, Japan). The instrument was calibrated with an aqueous solution of d10-(1)-camphorsulfonic acid (Yang et al., 1986Go). Proteins were dissolved in 10 mM sodium cacodylate, pH 5.0 and filtered using a 0.2 µm filter (Millipore). A quartz cell of 0.01 cm optical pathlength was used to record the spectra of proteins in the far-UV region (178–260 nm) at a protein concentration of 1 mg/ml. For measurements in the near-UV region (250–310 nm), a 0.2 cm optical pathlength cell and a protein concentration of 0.5 mg/ml were used. CD spectra were acquired at a scan speed of 20 nm/min, using a 2 nm bandwidth and a response time of 1 s. Spectra were signal-averaged over four scans. The solvent dichroic absorbance contribution was subtracted using the Jasco software.

Thermal denaturation experiments

Thermal denaturation of the enzyme variants was followed spectrophotometrically at a protein concentration of 0.75 mg/ml in 50 mM sodium acetate, pH 5.0. Absorption spectra were recorded between 260 and 305 nm as a function of temperature, from 20 to 80°C, in 2–3°C steps, using a Perkin-Elmer spectrometer with a thermostatted cell holder. Temperature increments were measured with a thermocouple thermometer (Hanna) placed in another quartz cell filled with 50 mM sodium acetate also located in the cell holder. Following each temperature increment, the system was equilibrated during a 2 min pause before each measurement. Each spectrum was corrected for the temperature-dependent change in volume and enzyme concentration before calculating the fourth derivative as described elsewhere (Lange et al., 1996Go). A method that exploits the whole spectral region and determines an average transition (Torrent et al., 1999Go) was used to calculate a parameter for each spectrum named the cumulative difference amplitude (CDA). The CDA values were plotted against temperature and the unfolding transition curves were fitted to a two-state thermodynamic model combined with sloping linear functions for the native and denatured states as described elsewhere (Torrent et al., 1999Go). The standard errors of T1/2 were <1%.

Calculation of helix propensity

The residue sequences from 1 to 17 of each variant were introduced into the helix/coil transition algorithm AGADIR1s-2 (Lacroix et al., 1998Go), which can be found at http://www.embl-heidelberg.de/services/serrano/agadir/agadir-star.html . Each sequence was introduced with the C-terminus amidated in order to avoid the introduction of an additional negative charge not present in the protein. Although the {alpha}-helix 1 of HP-RNase extends only from residues 4 to 12 (Pous et al., 2000Go), the flanking residues were included to take into consideration local motifs. The program provides the global helical propensity of the whole peptide.


    Results
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
N-terminal variants of HP-RNase

PM5 is an HP-RNase variant whose N-terminal sequence (residues 1–21) is that of BS-RNase. As can be seen in Figure 1AGo, only five residues are different between PM5 and PM9 (wild-type enzyme). Temperature-induced unfolding experiments showed that these changes were enough to render PM5 more resistant to thermal denaturation than the wild-type enzyme, the difference in T1/2 being nearly 5°C (Canals et al., 1999Go) (see also Table IGo).

CD spectra at 10°C and steady-state kinetic parameters for the cleavage of poly(C) and the hydrolysis of C>p were determined for both enzymes. The shapes of the near- and far-UV CD spectra were almost overlapping (Figure 2Go). The {alpha}-helical content, calculated according to Chen et al. (Chen et al., 1972Go), was 19.9 and 20.4% for PM5 and PM9, respectively. These values are very similar to those described in the literature, obtained from the crystal structure of the PM7 HP-RNase variant (20.3%) (Pous et al., 2000Go) or from the secondary structure of the wild-type enzyme solved by a 1H/15N NMR study (23.4%) (El-Joubary et al., 1999Go). The steady-state kinetic parameters shown in Table IGo are very similar for both enzymes, as described elsewhere (Canals et al., 1999Go). All these results suggest that the broad structures of wild-type HP-RNase and its PM5 variant are similar, and therefore differences in stability should arise from differences in specific atom-to-atom interactions.



View larger version (24K):
[in this window]
[in a new window]
 
Fig. 2. (a) Far- and (b) near-UV CD spectra at 10°C of proteins PM5 (······), PM9 (– – –), RNase A (—) and PM5-124 (–··–).

 
The positions under study at the N-terminal edge (Figure 1BGo) correspond to very exposed residues according to the solvent-accessible surface area calculated using the DSSP program (Kabsch and Sander, 1983Go). In addition, using the program CONTACT from the CCP4 package (Collaborative Computational Project, No. 4, 1994), the substituted residues do not establish a significant number of contacts with other, more distant residues in the sequence (results not shown). Moreover, none of these residues belong to any of the subsites or to the active site described elsewhere (Nogués et al., 1998Go).

In order to dissect the contribution of a particular residue change to the increase in stability, variants, each carrying a single one of the five replacements already present in PM5, were generated by site-directed mutagenesis on pM9. Variants carrying the substitutions R4A, K6A, Q9E, D16G and S17N were expressed and purified to homogeneity according to the procedures described in Canals et al. (Canals et al., 1999Go). Protein integrity was checked by MALDI-TOF mass spectrometry and homogeneity by reversed-phase chromatography (results not shown). Steady-state kinetic parameters for the hydrolysis of C>p and cleavage of poly(C) were very similar to those found for PM5 and PM9 variants (Table IGo).

Temperature unfolding and refolding of each variant were followed spectrophotometrically. The unfolding transition curves obtained from the CDA analysis were nearly 100% reversible and the calculated T1/2 values are listed in Table IGo. Excluding the substitution of Ser17 to Asn, the other changes all led to an increased T1/2 relative to PM9. The T1/2 increase was more apparent in the case of the substitutions of Arg4 to Ala and Lys6 to Ala, being their {Delta}T1/2 of –2.7 and –2.2°C, respectively ({Delta}T1/2 is the difference between the T1/2 of PM9 and each of their variants). Positions 4, 6 and 9 are located in the {alpha}-helix 1 of the HP-RNase molecule, whereas positions 16 and 17 are located in the hinge loop that connects this helix with the rest of the protein (El-Joubary et al., 1999Go; Pous et al., 2000Go). The helical propensity of the N-terminal peptide (residues 1–17) of PM5 and PM9 proteins, and also of the single point variants of PM9: R4A, K6A and Q9E, were predicted using the program AGADIR1s-2 (Lacroix et al., 1998Go).

A plot of the helical propensity predicted for each of the N-terminal peptides analyzed against {Delta} T1/2 is shown in Figure 3Go. A good correlation between the two parameters is found (r = 0.978), suggesting that the increase in conformational stability is directly related to the stabilization of {alpha}-helix 1.



View larger version (10K):
[in this window]
[in a new window]
 
Fig. 3. Correlation analysis between {Delta}T1/2 (defined as the difference between the T1/2 of PM9 and each of the variants) of the proteins PM9, PM5, R4A, K6A and Q9E and their corresponding average helical propensity predicted with AGADIR1s-2. The experimental conditions introduced into the program were pH 7.0, 278 K and ionic strength 0.1 M.

 
Deletion of the C-terminus of HP-RNase.

It has been described elsewhere (Bal and Batra, 1997Go) that deleting the last four residues of HP-RNase (Glu–Asp–Ser–Thr) yields an enzyme (namely HPR1-124) with increased thermal stability. In the same work, the authors suggested that the last eight residues of the HP-RNase are in an {alpha}-helix structure. This result is not in agreement with the recently reported three-dimensional structure of two HP-RNase variants (Pous et al., 2000Go; Canals et al., 2001Go) or with the secondary structure of HP-RNase assigned from its 1H and 15N NMR spectra (El-Joubary et al., 1999Go). Residues 116–124 are in a ß-strand conformation, whereas the last four residues appear to be disordered.

In order to test whether this deletion could enhance the thermal stability of PM5 variant, we constructed a new variant of PM5 which lacked the four C-terminal residues of the sequence. This variant, named PM5-124, is different at its N-terminus from the HPR1-124 reported elsewhere (Bal and Batra, 1997Go). The former carries an extra Met together with the five internal substitutions, while the latter carries the extra dipeptide, Ala–Ser, at positions –2 and –1. In the structure of HP-RNase (Pous et al., 2000Go), the N- and C-terminal edges of the protein are far apart one from the other (Figure 1BGo). Hence it can be assumed that the amino acid differences located at the N-terminus have a negligible effect on the protein C-terminal end.

PM5-124 was expressed and purified to homogeneity according to the procedures described in Canals et al. (Canals et al., 1999Go). Protein integrity was checked by MALDI-TOF mass spectrometry and its homogeneity by reversed-phase chromatography (results not shown). Steady-state kinetic parameters of PM5-124 for the cleavage of poly(C) and the hydrolysis of C>p were slightly lower than those found for PM5 (Table IGo); however, the kcat/KM value was found to be identical for both proteins. Far- and near-UV CD spectra of PM5-124 were also measured at 10°C. The shape of the curves were very similar to those of PM5 (Figure 2Go) with the {alpha}-helical content being 23.5%. Analysis of thermal stability was performed and the unfolding transition curve was 100% reversible (not shown). The PM5-124 truncated protein presents a T1/2 value equal to that found for PM5 (Table IGo), indicating that this C-terminal deletion does not contribute to the stabilization of the protein.


    Discussion
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Subtilisin-mediated cleavage of RNase A renders a bimolecular compound (RNase S) formed by two tightly associated polypeptides (Richards and Vithayathil, 1959Go). These polypeptides are named S-peptide (residues 1–20 of RNase A) and S-protein (residues 21–124) and this nomenclature has been extended to other members of the ribonuclease superfamily such as HP-RNase and BS-RNase. In previous work (Canals et al., 1999Go), we showed that replacement of the S-peptide sequence of HP-RNase by that of the BS-RNase leads to a protein (PM5) with improved thermal stability. The generated substitutions are located in the {alpha}-helix of the S-peptide and in the hinge loop that connects S-peptide and S-protein. The fact that mutations in this region could change the stability of the ribonuclease is not surprising. Interaction between S-peptide and S-protein was soon revealed to be important for the RNase A folding and stability. S-protein refolding experiments showed that the recovery of native protein was only complete when it was carried out in the presence of the S-peptide (Kato and Anfinsen, 1969Go). Two hydrophobic residues in S-peptide, Phe8 and Met13, are thought to be particularly important for binding to the protein (Scoffone et al., 1967Go; Hearn et al., 1971Go). However in our case, the changed residues are not located in the interface between the S-peptide and the S-protein. They are solvent-exposed and make only a small number of van der Waals contacts with the rest of the protein. Therefore, it is likely that the mutations have not led to an improvement of the packing between this peptide and the rest of the molecule. The stability increase in PM5 could be due to an increase in the foldability of the S-peptide itself. Recently, a study with the RNase S system showed that the {alpha}-helix also plays a key role in stabilizing this complex (Goldberg and Baldwin, 1999Go): from folding and unfolding kinetics of denatured S-peptide combined with folded S-protein, it was shown that the binding at the transition state of the S-peptide to the S-protein requires the formation of this {alpha}-helix and the correct positioning of Phe8 (Met13 contributes to a lesser extent).

We constructed variants carrying single point mutations in order to evaluate the importance of each change in the increase of thermal stability. The effect of the different mutations is nearly additive. The mutations introduced into the {alpha}-helix give a more pronounced effect than those found in the hinge loop where they could be more easily accommodated. Substitutions at positions 4 and 6 probably enhance {alpha}-helix stability. Position 4 corresponds to the first residue of the {alpha}-helix in HP-RNase (El-Joubary et al., 1999Go) and also in the PM7 HP-RNase variant (Pous et al., 2000Go). In PM9 (Met-1 HP-RNase), this position is occupied by Arg. This residue, at this position, destabilizes the {alpha}-helix because the positively charged side chain makes unfavorable interactions with the partial helix dipole created by the impaired amide protons. When an Ala is found at this position, these unfavorable interactions are eliminated. The increase in thermal stability after the change of Lys6 to Ala can also be reasoned in terms of helical stability. Substitutions of internal {alpha}-helix residues by Ala in model peptides and proteins usually result in more stable {alpha}-helices [for a review, see Fersht (Fersht, 1998Go)]. Substitution of Gln9 by Glu results in a higher helical propensity value for the peptide containing Glu residue (Figure 3Go). Amino acid replacements that lead to the appearance or elimination of net charges (positions 4, 6 and 9) could alter charge–charge interactions, explaining the change in stability. However, analysis of the altered positions in the PM7 structure does not reveal charge–charge interactions with the rest of the protein. In addition, Figure 3Go suggests that the increase in T1/2 is mainly a consequence of the increase in the stability of {alpha}-helix-1.

Designing new mutations that could increase this helical propensity even more, without altering non-local interactions, should produce even more stable HP-RNase variants. This strategy has been used elsewhere in the CheY protein (López-Hernández et al., 1997Go), {alpha}-spectrin SH3 domain (Blanco et al., 1999Go) and the activation domain of human carboxypeptidase A (Villegas et al., 1996Go), among others.

A previous study (Bal and Batra, 1997Go) indicated that a recombinant and truncated form of HP-RNase (HPR1-124) presented greater thermostability and also greater ribonuclease activity and a lower helical content than the corresponding recombinant non-truncated form. The possibility that a deletion in the HP-RNase could render a more thermostable enzyme would be of great interest in the design of cytotoxic HP-RNases because this increase in stability does not mean the appearance of new epitopes in the protein. Thus, a C-terminal-deleted ribonuclease could be a good template on which to introduce the desired mutations.

As we expected from the three-dimensional structure of PM7, our CD results do not indicate that the helical content of PM5-124 is less than that of PM5. In addition, the truncated enzyme has neither increased catalytic activity nor enhanced thermostability. HP-RNase and HPR1-124 differ from PM5 and PM5-124, respectively, in the N-terminal sequence: whereas the former has two additional residues at the N-terminus (Ala–Ser), the latter carries five mutations in the S-peptide and a Met residue at position –1. Analysis of the PM7 three-dimensional structure does not shed light on how the N-terminal changes could account for the different behavior of the two truncated forms.

In our studies, truncation of the C-terminal edge of PM5 did not appear to be a good strategy for increasing the stability of the enzyme. However, it could be concluded from our results that the engineering of the N-terminal {alpha}-helix of HP-RNase in order to increase its helical propensity could be a valid strategy in constructing variants of HP-RNase with higher stability.


    Notes
 
1 To whom correspondence should be addressed. E-mail: maria.vilanova{at}udg.es. Back


    Acknowledgments
 
This work was supported by grants BMC2000-0138-CO2-02 from the Ministerio de Ciencia y Tecnología, Spain, SGR2000-64 and SGR2001-00196 from the Generalitat de Catalunya and INTAS-RFBR97-245 from the Russian Foundation of Basic Research. M.B. acknowledges a predoctoral (FPI) fellowship from Comissió Interdepartamental de Recerca i Tecnologia (CIRIT), Generalitat de Catalunya, Spain. We are also indebted to the Fundació ‘Maria Francesca de Roviralta’, Barcelona, Spain, for equipment purchase grants.


    References
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Akasako,A., Haruki,M., Oobatake,M. and Kanaya,S. (1997) J. Biol. Chem., 272, 18686–18693.[Abstract/Free Full Text]

Anfinsen,C.B. (1973) Science, 181, 223–230.[ISI][Medline]

Bal,H.P. and Batra,J.K. (1997) Eur. J. Biochem., 245, 465–469.[Abstract]

Beintema,J.J., Wietzes,P., Weickman,J.L. and Glitz,D.G. (1984) Anal. Biochem., 136, 48–64.[ISI][Medline]

Blanco,F.J., Angrand,I. and Serrano,L. (1999) J. Mol. Biol., 285, 741–753.[CrossRef][ISI][Medline]

Boix,E., Nogués,M.V., Schein,C.H., Benner,S.A. and Cuchillo,C.M. (1994) J. Biol. Chem., 269, 2529–2534.[Abstract/Free Full Text]

Canals,A., Ribó,M., Benito,A., Bosch,M., Mombelli,E. and Vilanova,M. (1999) Protein Express. Purif., 17, 169–181.[CrossRef][ISI][Medline]

Canals,A., Pous,J., Guasch,A., Benito,A., Ribó,M., Vilanova,M. and Coll,M. (2001) Structure, 9, 967–976.[CrossRef][ISI][Medline]

Chen,Y.-H., Yang,J. T. and Martínez,H.M. (1972) Biochemistry, 11, 4120–4131.[ISI][Medline]

El-Joubary,A. et al. (1999) J. Biomol. NMR, 15, 265–266.[CrossRef][ISI][Medline]

Fersht,A. (ed.) (1998) Structure and Mechanism in Protein Science: a Guide to Enzyme Catalysis and Protein Folding. Freeman, San Francisco, pp. 508–539.

Goldberg,J.M. and Baldwin,R.L. (1999) Proc. Natl Acad. Sci. USA, 96, 2019–2024.[Abstract/Free Full Text]

Hearn,R.P., Richards,F. M., Sturtevant,J.M. and Watt,G.D. (1971) Biochemistry, 10, 806–816.[ISI][Medline]

Juncosa-Ginestà,M., Pons,J., Planas,A. and Querol,E. (1994). Biotechniques, 16, 820–824.[ISI][Medline]

Kabsch,W. and Sander,C. (1983) Biopolymers, 22, 2577–2637.[ISI][Medline]

Kato,I. and Anfinsen,C.B. (1969) J. Biol. Chem., 244, 1004–1007.[ISI][Medline]

Klink,T.A. and Raines,R.T. (2000) J. Biol. Chem., 275, 17463–177467.[Abstract/Free Full Text]

Koradi,R., Billeter,M. and Wuthrich,K. (1996) J. Mol. Graphics, 14, 51–53.[CrossRef][ISI][Medline]

Lacroix,E., Viguera,A.R. and Serrano L. (1998) J. Mol. Biol., 284, 173–191.[CrossRef][ISI][Medline]

Lange,R., Frank,J., Saldana,J.L. and Balny,C. (1996) Eur. Biophys. J., 24, 277.[ISI]

Leatherbarrow,J.R. (1987) ENZFITTER. Elsevier Biosoft, Cambridge.

Leland,P. A., Staniszewski,K. E., Kim,B.-M. and Raines,R. T. (2001) J. Biol. Chem., 276, 43095–43102.[Abstract/Free Full Text]

Loladze,V.V., Ibarra-Molero,B., Sanchez-Ruiz,J.M. and Makhatadze,G. (1999) Biochemistry, 38, 16419–16423.[CrossRef][ISI][Medline]

López-Hernández,E., Cronet,P., Serrano,L. and Muñoz,V. (1997) J. Mol. Biol., 266, 610–620.[CrossRef][ISI][Medline]

Mazarella,L., Capasso,S., Demasi,D., Di’Lorenzo,G., Mattia,C.A. and Zagari,A. (1993) Acta Crystallogr., D49, 389–402.

Nogués,M.V., Moussaoui,M., Boix,E., Vilanova,M., Ribó,M. and Cuchillo,C.M. (1998) Cell. Mol. Life Sci., 54, 766–774.[CrossRef][ISI][Medline]

Perry,J. and Wetzel,R. (1984) Science, 226, 555–557.[ISI][Medline]

Pous,J., Canals,A., Terzyan,S.S., Guasch,A., Benito,A., Ribó,M., Vilanova,M. and Coll,M. (2000) J. Mol. Biol., 303, 49–59.[CrossRef][ISI][Medline]

Ribó,M., Benito,A., Canals,A., Nogués,M.V., Cuchillo,C.M. and Vilanova,M. (2001), Methods Enzymol., 341, 221–234.[CrossRef][ISI][Medline]

Richards,F.M. and Vithayathil,P.J. (1959) J. Biol. Chem., 234, 1459–1465.[Free Full Text]

Scoffone,E., Rocchi,R., Marchiori,F., Moroder,L., Marsotto,A. and Tamburro A. (1967) J. Am. Chem. Soc., 89, 5450.[ISI][Medline]

Serrano,L., Kellis,J.T. Jr., Cann,P., Matouschek,A. and Fersht,A.R. (1992) J. Mol. Biol., 224, 783–804.[ISI][Medline]

Torrent,J., Connelly,J.P., Coll,M.G., Ribó,M., Lange,R. and Vilanova M. (1999) Biochemistry, 38, 15952–15961.[CrossRef][ISI][Medline]

Villegas,V., Viguera,A.R., Avilés,F.X. and Serrano,L. (1996) Fold. Des., 1, 29–34.[ISI][Medline]

Wlodawer,A., Svensson,L.A., Sjolin,L. and Gilliland,G.L. (1988) Biochemistry, 27, 2705–2717.[ISI][Medline]

Yang,J.T., Wu,C.-S.C. and Martínez,H.M. (1986) Methods Enzymol., 130, 208–269.[ISI][Medline]

Youle,J.R. and D’Alessio,G. (1997) In D’Alessio,G. and Riordan,J.F. (eds), Ribonucleases, Structures and Functions. Academic Press, New York, pp. 491–514.

Received March 8, 2002; revised August 7, 2002; accepted August 26, 2002.





This Article
Abstract
FREE Full Text (PDF)
Alert me when this article is cited
Alert me if a correction is posted
Services
Email this article to a friend
Similar articles in this journal
Similar articles in ISI Web of Science
Similar articles in PubMed
Alert me to new issues of the journal
Add to My Personal Archive
Download to citation manager
Search for citing articles in:
ISI Web of Science (1)
Request Permissions
Google Scholar
Articles by Benito, A.
Articles by Vilanova, M.
PubMed
PubMed Citation
Articles by Benito, A.
Articles by Vilanova, M.